Tetracyclic compounds and their salts, compositions, and methods for their use

PH12022550360B1Active Publication Date: 2026-11-06SENHWA BIOSCIENCES INC
0 Cites 0 Cited by

Patent Information

Application Number
PH12022550360
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-02-14
Publication Date
2026-11-06
Estimated Expiration
2042-02-14
Patent Text Reader

Abstract

The present invention includes 2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia1,11b-diaza-benzo[c]fluorene-6-carboxylic acid (5-methyl-pyrazin-2-ylmethyl)-amide (Compound I) or a pharmaceutically acceptable salt thereof for use in treating cancer with PALB2 mutation and / or BRCA2 mutation.
Need to check novelty before this filing date? Find Prior Art